Interferon-γ Release Assay for Cytomegalovirus (IGRA-CMV) for Risk Stratification of Posttransplant CMV Infection: Is It Time to Apply IGRA-CMV in Routine Clinical Practice?

Affiliations

Comment

Sung-Han Kim. Clin Infect Dis. 2020.

. 2020 Dec 3;71(9):2386-2388.

doi: 10.1093/cid/ciz1211.

¹ Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

No abstract available

Keywords: cell-mediated immune response; cytomegalovirus; transplant.

Comment on

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
Chemaly RF, El Haddad L, Winston DJ, Rowley SD, Mulane KM, Chandrasekar P, Avery RK, Hari P, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, Dadwal SS, Blanchard T, Shah DP, Jiang Y, Ariza-Heredia E. Chemaly RF, et al. Clin Infect Dis. 2020 Dec 3;71(9):2365-2374. doi: 10.1093/cid/ciz1210. Clin Infect Dis. 2020. PMID: 32076709 Free PMC article.
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial.
Jarque M, Crespo E, Melilli E, Gutiérrez A, Moreso F, Guirado L, Revuelta I, Montero N, Torras J, Riera L, Meneghini M, Taco O, Manonelles A, Paul J, Seron D, Facundo C, Cruzado JM, Gil Vernet S, Grinyó JM, Bestard O. Jarque M, et al. Clin Infect Dis. 2020 Dec 3;71(9):2375-2385. doi: 10.1093/cid/ciz1209. Clin Infect Dis. 2020. PMID: 32076718 Clinical Trial.